Joseph Hargett

Joseph Hargett

Despite hailing from the Greater Cincinnati, Ohio area, Joseph Hargett has spent nearly the past decade elbow-deep in Wall Street.  Specializing in financial writing, options strategies and stock-market analysis, Joseph cut his teeth in the research department of Cincinnati-based Schaeffer’s Investment Research.

While at Schaeffer’s, Joseph wrote market, stock and options commentary for SchaeffersResearch.com, and was lead editor for The Options Advisor (the nation’s leading options newsletter).

Joseph has since moved on to become a prolific Forbes contributor in the options realm, as well as a lead copy editor and contributor for a well respected investment newsletter publisher.  Joseph’s commentary has appeared in a plethora of media outlets, including The Wall Street JournalThe New York TimesMoney Show Digest, Reuters, CBE MarketWatch and Sentiment Magazine.

Recent Articles

MannKind Corporation Earnings Preview: 2 Trades for MNKD Stock

Ahead of MannKind earnings, investors are focusing on Afrezza sales, guidance and the drug pipeline for MNKD stock.

Friday’s Vital Data: Pfizer Inc. (PFE), Twitter Inc (TWTR) and Starbucks Corp. (SBUX)

Calls flood Pfizer (PFE) on Allergan (AGN) merger. Twitter (TWTR) growth concerns won't fade. Starbucks (SBUX) traders indecisive.

Thursday’s Vital Data: Bank of America Corp (BAC), GoPro Inc (GPRO) and Facebook Inc (FB)

BofA (BAC) calls are popular on Fed news and price target hike, GoPro (GPRO) calls fall flat after earnings and Facebook (FB) eyes the Indian market.

SBUX Earnings Preview: 2 Trades for Starbucks Stock

Wall Street is expecting solid growth from SBUX earnings, but options traders are loading up on protection for Starbucks stock.

Wednesday’s Vital Data: Apple Inc. (AAPL), Rite Aid Corporation (RAD) and Twitter Inc (TWTR)

Apple (AAPL) calls are popular amid earnings, Rite Aid (RAD) arbitrage speculation spikes and Twitter (TWTR) volume jumps on earnings.